Presented by Jordan Johnson, MSHA

From the AAMD Virtual 46th Annual Meeting
June 6 -10, 2021

NOTE: If you earned CE Credits for this session during the AAMD Virtual 46^thAnnual Meeting, you will not be eligible to earn CE Credits for it again.

Medical Dosimetry is far more than a plan. The revenue aspect is critical for the viability of the department and service line. Ensuring that those responsible for the work understand the rules and all of the changes is crucial for timely payment. Post-COVID, as hospitals struggle to ramp back up, capturing all charges correctly is critical. This requires knowing the rules, where to look, and who to communicate with. This is not an automated task. Different modalities and protocols generate different charges. Now mix in the value-based care approach of the RO APM and it gets even more complex. So, how does the medical dosimetrist fit into this model and what can they do? What are providers and hospitals doing as a result of the changes? This session will discuss/inform on these important details.

Learner Outcomes:

1. Identify where the rules regulations come from for correct billing practices
2. Create a strategy for ensuring the correct codes are captured
3. Clarify where the dosimetry field is going and how the new technologies will be applied
4. Discuss and dissect the caveats when it comes to orders/documentation

Educational Level: Entry Level

Presenter:
Jordan Johnson, MSHA, iMPaCT is one of the nation's leading healthcare strategists with a focus on billing, coding, value, transparency, and compliance. He has over 12 years of advanced healthcare experience, with extensive experience in clinical, operational, and administrative oncology. He is a content expert in the Oncology RCM process and has served as an expert in litigation on the topic and policy creation. He also creates optimization and viability strategy based on data by associating cost to outcomes to influence operations. His transparency impact approaches have also been adopted by many leaders to increase staff engagement and shift culture. He has created several industry-leading software solutions, including analytic value identification and visualization tools. He is first and foremost a patient advocate and has served on many committees and drafted legislation to increase patient safety, quality, and value. His passion and resilience as an advocate drive from having a very personal connection to Cancer through the diagnosis, treatment and passing of both parents. Jordan does not believe in the status quo in the current workflow, agenda, nor operations within cancer care. Rather he believes that healthcare and oncology models are changing and with the proper data-driven guidance, education, and analytics, one can ensure quality while maintaining financial and clinical viability. Though these changes will be challenging, they must be viewed as an opportunity. He is committed to putting action in defining value and quality. As a consultant, Mr. Johnson has tested the tools, education, theories, and integrations with 300+ clients for various strategic plans at rural facilities, systems/networks, payers, vendors, and providers. He is trusted by many to help lead the way for transformation to value-based Oncology care. His current work with price transparency has been featured by the Wall Street News Journal and is providing the framework for value-based oncology, viability, and access to care.